SPRY fund manager activity
ARS Pharmaceuticals, Inc · Nasdaq. Reported by 4 tracked fund managers in their 13F filings, Q3 2024 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ron Baron - Baron Capital | Sold out | — | — | 0.00% | Aug 14, 2026 |
| Daniel Loeb - Third Point | No change | 1,000,000 | $8,010,000 | 0.17% | Aug 14, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Ron Baron - Baron Capital | Added | 1,273,341 | $10,224,928 | 0.03% | May 15, 2026 |
| Daniel Loeb - Third Point | Added | 1,000,000 | $8,030,000 | 0.39% | May 15, 2026 |